chr17-46768172-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_030753.5(WNT3):c.*8+140G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0169 in 1,246,776 control chromosomes in the GnomAD database, including 258 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 20 hom., cov: 32)
Exomes 𝑓: 0.017 ( 238 hom. )
Consequence
WNT3
NM_030753.5 intron
NM_030753.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.606
Publications
2 publications found
Genes affected
WNT3 (HGNC:12782): (Wnt family member 3) The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 98% amino acid identity to mouse Wnt3 protein, and 84% to human WNT3A protein, another WNT gene product. The mouse studies show the requirement of Wnt3 in primary axis formation in the mouse. Studies of the gene expression suggest that this gene may play a key role in some cases of human breast, rectal, lung, and gastric cancer through activation of the WNT-beta-catenin-TCF signaling pathway. This gene is clustered with WNT15, another family member, in the chromosome 17q21 region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 17-46768172-C-T is Benign according to our data. Variant chr17-46768172-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1318109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.014 (2140/152316) while in subpopulation NFE AF = 0.0214 (1457/68032). AF 95% confidence interval is 0.0205. There are 20 homozygotes in GnomAd4. There are 1015 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR,Unknown gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0141 AC: 2140AN: 152198Hom.: 20 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2140
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0173 AC: 18967AN: 1094460Hom.: 238 AF XY: 0.0171 AC XY: 9352AN XY: 547720 show subpopulations
GnomAD4 exome
AF:
AC:
18967
AN:
1094460
Hom.:
AF XY:
AC XY:
9352
AN XY:
547720
show subpopulations
African (AFR)
AF:
AC:
70
AN:
25586
American (AMR)
AF:
AC:
88
AN:
31760
Ashkenazi Jewish (ASJ)
AF:
AC:
74
AN:
21380
East Asian (EAS)
AF:
AC:
0
AN:
34300
South Asian (SAS)
AF:
AC:
140
AN:
68714
European-Finnish (FIN)
AF:
AC:
1254
AN:
34354
Middle Eastern (MID)
AF:
AC:
9
AN:
3424
European-Non Finnish (NFE)
AF:
AC:
16674
AN:
827112
Other (OTH)
AF:
AC:
658
AN:
47830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
965
1930
2895
3860
4825
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0140 AC: 2140AN: 152316Hom.: 20 Cov.: 32 AF XY: 0.0136 AC XY: 1015AN XY: 74476 show subpopulations
GnomAD4 genome
AF:
AC:
2140
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
1015
AN XY:
74476
show subpopulations
African (AFR)
AF:
AC:
165
AN:
41574
American (AMR)
AF:
AC:
71
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
13
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
15
AN:
4824
European-Finnish (FIN)
AF:
AC:
354
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1457
AN:
68032
Other (OTH)
AF:
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
103
205
308
410
513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 16, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.